Northern Trust Corp Humacyte, Inc. Transaction History

Northern Trust Corp

$658 Billion
Q1 2025

A detailed history of Northern Trust Corp transactions in Humacyte, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 925,395 shares of HUMA stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

925,395

Previous 901,194 2.69%

Holding current value

$1.99 Million

Previous $4.55 Million 65.24%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$1.71 - $5.18 $41,383 - $125,361	24,201 Added 2.69%	925,395 $1.58 Million
Q4 2024 Feb 14, 2025	BUY	$3.46 - $5.81 $320,769 - $538,633	92,708 Added 11.47%	901,194 $4.55 Million
Q3 2024 Nov 13, 2024	BUY	$5.11 - $9.46 $1.21 Million - $2.23 Million	236,024 Added 41.23%	808,486 $4.4 Million
Q2 2024 Aug 14, 2024	BUY	$2.87 - $9.1 $65,197 - $206,724	22,717 Added 4.13%	572,462 $2.75 Million
Q1 2024 May 14, 2024	SELL	$2.57 - $4.84 $39,480 - $74,352	-15,362 Reduced 2.72%	549,745 $1.71 Million
Q4 2023 Feb 13, 2024	BUY	$1.99 - $3.12 $92,576 - $145,145	46,521 Added 8.97%	565,107 $1.6 Million
Q3 2023 Nov 13, 2023	BUY	$2.75 - $4.48 $51,089 - $83,229	18,578 Added 3.72%	518,586 $1.52 Million
Q2 2023 Aug 11, 2023	BUY	$2.86 - $4.97 $40,529 - $70,429	14,171 Added 2.92%	500,008 $1.43 Million
Q1 2023 May 15, 2023	SELL	$2.11 - $3.25 $50,777 - $78,211	-24,065 Reduced 4.72%	485,837 $1.5 Million
Q4 2022 Feb 13, 2023	BUY	$2.02 - $3.62 $554,005 - $992,821	274,260 Added 116.39%	509,902 $1.08 Million
Q3 2022 Nov 14, 2022	SELL	$1.22 - $5.14 $8,231 - $34,679	-6,747 Reduced 2.78%	235,642 $769,000
Q2 2022 Aug 12, 2022	BUY	$3.21 - $7.86 $386,163 - $945,558	120,300 Added 98.53%	242,389 $777,000
Q1 2022 May 13, 2022	SELL	$4.65 - $7.4 $10,634 - $16,923	-2,287 Reduced 1.84%	122,089 $862,000
Q4 2021 Feb 08, 2022	BUY	$7.25 - $11.6 $901,726 - $1.44 Million	124,376 New	124,376 $901,000

Others Institutions Holding HUMA

# of Institutions

181

Shares Held

59.9M

Call Options Held

1.05M

Put Options Held

877K

View Full List

About Humacyte, Inc.

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $221M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

More about HUMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Humacyte, Inc. Transaction History